14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026
HGER vs BCI: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on HGER vs BCI. Trailing 12-month operating profitability (HGER N/A vs BCI N/A) and valuation multiples (HGER N/M vs BCI N/M Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D ReinvestmentN/A
90D Engineering Disclosures0 Published
Investor FAQ HGER vs BCI Key Questions & Quantitative Answers
As of Nov 16, 2026, abrdn Bloomberg All Commodity Strategy K-1 Free ETF (BCI) is the stronger overall head-to-head candidate over Harbor Commodity All-Weather Strategy ETF (HGER) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). HGER carries a Unified Composite Score of 48.2/100 (HOLD) at $32.85 (N/M Forward P/E, N/A operating margin), whereas BCI carries 51.9/100 (HOLD) at $24.00 (N/M Forward P/E, N/A operating margin). Technically, HGER sits in a Neutral phase (RSI 27.1, UNCLASSIFIED options structure) and BCI sits in a Neutral phase (RSI 23.3, UNCLASSIFIED options structure).
HGER and BCI split Growth & Scale metrics: HGER posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with BCI at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, HGER generates N/A in USD-normalized revenue versus N/A for BCI. In operating R&D and SG&A reinvestment, HGER deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for BCI.
HGER and BCI trade at balanced relative valuation multiples. HGER trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas BCI trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HGER (N/A ROE) versus BCI (N/A ROE) capital efficiency.
In options market volatility and institutional positioning, HGER carries 11.7% implied volatility (2nd %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.17β · 17% Vol realized risk). By comparison, BCI carries 9.3% implied volatility (<1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.28β · 13% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.